Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 AIRS | Healthcare | $0.84 | 1.74M | $61.88M | -6.36 | ― | Strong Buy |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| AIRS | Airsculpt Technologies | 0.84 | -4.63 | -84.70% |
| Name | Price | % Change | |
|---|---|---|---|
| AIRS | $0.84 | -84.70% |
Airsculpt Technologies, Inc. (($AIRS)) has held its Q3 earnings call. Read on for the main highlights of the call. AirSculpt Technologies delivered a difficult but cautiously optimistic quarterly update, as
Meeting to be held on November 16 hosted by Maxim. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks
Lake Street lowered the firm’s price target on AirSculpt Technologies (AIRS) to $1 from $3 and keeps a Buy rating on the shares. AirSculpt’s Q3 and updated FY26 guidance “will
An update from Airsculpt Technologies ( ($AIRS) ) is now available. On November 5, 2026, AirSculpt entered a financing agreement with lenders and Blue Torch Finance for a $39 million
Reports Q3 revenue $31.94M, consensus $34.51M. Yogi Jashnani, Chief Executive Officer, stated: “While our third quarter results were below expectations, we identified the key drivers and are addressing them with
FY26 consensus $151.05M. Cuts FY26 adjusted EBITDA view to $9M-$10M from $12M-$14M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s
Airsculpt Technologies, Inc. (AIRS) is scheduled to report 3rd quarter earnings on 11/06/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Airsculpt Technologies, Inc. to post earnings
Lake Street analyst Ben Haynor initiated coverage of AirSculpt Technologies (AIRS) with a Buy rating and $3 price target AirSculpt’s core fat removal procedures were waylaid by GLP-1s, with same-center
Titan Partners initiated coverage of AirSculpt Technologies (AIRS) with a Buy rating and $5 price target The firm views the company as a premium provider of minimally invasive body-contouring procedures
AIRS (AirSculpt Technologies) was downgraded by three AI models on TipRanks as weak fundamentals and a pronounced downtrend in the share price outweighed early signs of operational stabilization. The models
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| AIRS | Mar 5, 2027TBA | $61.88M | $-0.04 | $31.45M | -0.29 | -6.36 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
